Update on Osteoporosis Screening and Management.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] Conflict of interest statement: Disclosure The authors have nothing to disclose. 5. Prim Care. 2019 Mar;46(1):175-190. doi: 10.1016/j.pop.2018.10.014. Epub 2018 Dec 24. Update on Osteoporosis. Yedavally-Yellayi S(1), Ho AM(2), Patalinghug EM(2). Author information: (1)Department of Family Medicine, Family Medicine Residency Program, Beaumont Health Troy, 44250 Dequindre Road, Sterling Heights, MI 48314, USA; Oakland University William Beaumont School of Medicine, O'Dowd Hall, 586 Pioneer Drive, Rochester, MI 48309, USA. Electronic address: Srikala.yedavally@beaumont.edu. (2)Department of Family Medicine, Family Medicine Residency Program, Beaumont Health Troy, 44250 Dequindre Road, Sterling Heights, MI 48314, USA. Osteoporosis is often a silent disease that reveals itself at the time of a fracture. Assessing risk factors and applying appropriate screening guidelines in the population at risk can potentially decrease the looming high disease burden in the United States. FRAX is a validated tool that can be used to determine 10-year fracture risk to assist in medical decision making. Bone mineral density testing of the hip or spine using DEXA can be used alone or in combination with FRAX to determine patients' risk for fracture and determine if patients are candidates for treatment of osteoporosis. Copyright © 2018 Elsevier Inc. All rights reserved. DOI: 10.1016/j.pop.2018.10.014